Medical News

RSS

New Jersey Superior Court links Roche's Accutane to IBD

In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe case of IBD and thereafter had his colon removed. The jury awarded compensatory damages of $25.16 million to Andy, now in his thirties.

19 Feb 2010

Permitting private health insurance may not obviously weaken public health system

A single payer, fully government funded health care system has often been equated with core Canadian values. It is often argued that a single insurer, the government, is critical to the integrity of the system. Permitting private health insurance, it is claimed, would weaken the public system.

19 Feb 2010

Mechanism by which Plasmodium replicates itself in human blood to spread disease identified

Malaria remains one of the most deadly infectious diseases. Yet, how Plasmodium, the malaria parasite, regulates its infectious cycle has remained an enigma despite decades of rigorous research.

19 Feb 2010

Landmark collaboration to launch largest study of breast cancer in Latin American women

The largest study ever of breast cancer in Latin American women is being launched this year in a unique multi-country, public/private partnership with $1 million in additional funding from the world’s largest breast cancer organization, Susan G. Komen for the Cure®.

19 Feb 2010

WHO urges medical aid agencies to remain in Haiti as health care system is rebuilt

On Wednesday, the WHO "urged medical aid agencies to stay in Haiti as long as possible while health care is rebuilt following last month's devastating earthquake," Agence France-Presse reports.

19 Feb 2010

University of California researchers awarded AAN's 2010 Potamkin Prize

The American Academy of Neurology (AAN) is awarding its 2010 Potamkin Prize to two researchers for their work in Alzheimer's disease and frontotemporal lobar degeneration (FTLD), a common type of dementia. Bruce L. Miller, MD, and Lennart Mucke, MD, both of the University of California San Francisco will receive the Award during the AAN's 62nd Annual Meeting in Toronto, April 10 - 17, 2010. The AAN Annual Meeting is the world's largest gathering of neurologists with more than 2,000 presentations made on the latest advances in neurologic research.

19 Feb 2010

Freedom Healthnet asserts the benefits of private health insurance

Freedom Healthnet (http://www.freedomhealthnet.com/http://www.freedomhealthnet.com/) today affirmed the benefits of private health insurance as the company prepares to launch a range of new products.

19 Feb 2010

11 cities to join DASH FOR DAD national race series to end prostate cancer

DASH FOR DAD, the premier prostate cancer race series in the U.S., is a heartfelt tight-knit community event that brings together athletes, cancer survivors, physicians, caregivers, family members and friends. Proceeds from each 10K race are used to provide free prostate cancer testing for men in the local community of the event.

19 Feb 2010

HHS releases report highlighting health insurance premium increases

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius today unveiled a new report, Insurance Companies Prosper, Families Suffer: Our Broken Health Insurance System. The report highlights health insurance premium increases in states across the country and comes shortly after Anthem Blue Cross announced plans to raise rates on its California customers by as much as 39 percent, even after its parent company took in a profit of $2.7 billion in the previous quarter. The complete report is available at www.HealthReform.gov.

19 Feb 2010

Contrast-enhanced MRI may help physicians differentiate between rheumatoid and psoriatic arthritis

Contrast-enhanced magnetic resonance imaging (MRI) may help physicians differentiate between rheumatoid arthritis and psoriatic arthritis in the hand and wrist enabling more targeted therapies unique to each condition, according to a study in the March issue of the American Journal of Roentgenology. Contrast-enhanced MRI uses contrast media to improve the visibility of internal bodily structures.

19 Feb 2010

Roseville ROC commences cancer treatment with Elekta VMAT

The first treatments with Elekta Volumetric Modulated Arc Therapy (VMAT) began November 17, 2009 at Roseville Radiation Oncology Center (ROC) at Radiological Associates of Sacramento (RAS). RAS, a large private medical group, includes diagnostics as well as therapy in its centers. ROC treats 30-35 patients per day, mainly with prostate and breast lesions.

From Elekta 19 Feb 2010

Benefits of wartime camaraderie extend far beyond the battlefield: Study of U.S. Civil War veterans

Veterans who served in military units characterized by a strong esprit de corps were much less likely decades later to die of a stroke or heart condition than veterans from less cohesive companies, two UCLA economists have found.

19 Feb 2010

MetLife Mature Market Institute provides history of generations born since early 1900s

A series of publications from the MetLife Mature Market Institute provide a history of the generations born since the early 1900s. There are almost as many members of Gen Y (born 1977-1994) in the U.S. in comparison to the largest group, the Baby Boomers.

19 Feb 2010

DSM Pharmaceutical Products wins Profiles in Sustainability award

DSM Pharmaceutical Products, based in Parsippany, NJ, today announced that it has received a Profiles in Sustainability award from United Business Media and ICIS Chemical Business. United Business Media Limited is a leading global business media company and parent of InformexUSA, where the award was announced today in San Francisco.

19 Feb 2010

Most important osteoporosis meeting of 2010: More than 850 abstracts received

More than 850 abstracts have been received - guaranteeing broad global attendance at the year's most noteworthy platform for osteoporosis research. Don't miss the most important osteoporosis meeting of 2010, to be held in the center of Florence, Italy from May 5 to 8, 2010.

19 Feb 2010

PsychoGenics announces alliance with experimental neuropharmacology expert for specialized microdialysis services

PsychoGenics Inc. today announced the establishment of an exclusive alliance with Dr. Jan Kehr, an internationally recognized expert in experimental neuropharmacology, to provide specialized microdialysis services to complement PsychoGenics’ in vivo testing capabilities.

19 Feb 2010

Researchers develop new technique to automatically control anaesthesia during surgical operations

A team of researchers from the Canary Islands has developed a technique for automatically controlling anaesthesia during surgical operations. The new system detects the hypnotic state of the patient at all times and supplies the most appropriate dose of anaesthetic.

19 Feb 2010

SRI International establishes new Neurodegenerative Diseases Research Program

SRI International, an independent nonprofit research and development institute, announced today that a new Neurodegenerative Diseases Research Program has been established within its Center for Health Sciences. This new SRI group of neuroscientists and researchers working at the cutting edge of science brings $6.2 million of funding from the National Institutes of Health (NIH), including the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Environmental Health Sciences (NIEHS), and National Institute of General Medical Sciences (NIGMS).

19 Feb 2010

NIA supports FDA initiative to reduce radiation overexposure from medical imaging

National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.

19 Feb 2010

Tryton Medical announces implantation of Tryton stent for the first time in Portugal and Austria

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the Tryton® stent has been implanted for the first time in Portugal and Austria.

19 Feb 2010

Medical News

New Jersey Superior Court links Roche's Accutane to IBD

Permitting private health insurance may not obviously weaken public health system

Mechanism by which Plasmodium replicates itself in human blood to spread disease identified

Landmark collaboration to launch largest study of breast cancer in Latin American women

WHO urges medical aid agencies to remain in Haiti as health care system is rebuilt

University of California researchers awarded AAN's 2010 Potamkin Prize

Freedom Healthnet asserts the benefits of private health insurance

11 cities to join DASH FOR DAD national race series to end prostate cancer

HHS releases report highlighting health insurance premium increases

Contrast-enhanced MRI may help physicians differentiate between rheumatoid and psoriatic arthritis

Roseville ROC commences cancer treatment with Elekta VMAT

Benefits of wartime camaraderie extend far beyond the battlefield: Study of U.S. Civil War veterans

MetLife Mature Market Institute provides history of generations born since early 1900s

DSM Pharmaceutical Products wins Profiles in Sustainability award

Most important osteoporosis meeting of 2010: More than 850 abstracts received

PsychoGenics announces alliance with experimental neuropharmacology expert for specialized microdialysis services

Researchers develop new technique to automatically control anaesthesia during surgical operations

SRI International establishes new Neurodegenerative Diseases Research Program

NIA supports FDA initiative to reduce radiation overexposure from medical imaging

Tryton Medical announces implantation of Tryton stent for the first time in Portugal and Austria

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News